Jelli B, Taton O, D'Haene N, Remmelink M, Mekinda Z. Complete Response to Afatinib of an EGFR Exon 18 delE709_T710insD-Mutated Stage IV Lung Adenocarcinoma. EJCRIM [Internet]. 2021 Aug. 11 [cited 2026 Nov. 4];8(8). Available from: https://ejcrim.com/index.php/ejcrim/article/view/2749